ORIGINAL ARTICLE
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy
Laura TestaI,VI,
, Max ManoI, Roberto Jun AraiI, Renata Colombo BonadioI,VI, Sergio V. SerranoII, Marina M Costa ZorzettoII, Susanne CrocamoIII, Oren SmaletzIV, Ruffo Freitas-JuniorV, Paulo M. HoffI,VI
Corresponding author
I Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR
II Hospital de Cancer de Barretos, Fundaçao Pio XII, Barretos, SP, BR
III Instituto Nacional do Cancer - INCA, Rio de Janeiro, RJ, BR
IV Recepta Biopharma e Hospital Israelita Albert Einstein, Sao Paulo, SP, BR
V Universidade Federal de Goias, Goiania, GO, BR
VI Oncologia D'or, Sao Paulo, SP, BR
Read
1321
Timeswas read the article
461
Total PDF
860
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 22 | 2 | 24 |
| 2024 November | 37 | 27 | 64 |
| 2024 October | 47 | 40 | 87 |
| 2024 September | 31 | 28 | 59 |
| 2024 August | 49 | 30 | 79 |
| 2024 July | 46 | 29 | 75 |
| 2024 June | 37 | 20 | 57 |
| 2024 May | 55 | 17 | 72 |
| 2024 April | 58 | 22 | 80 |
| 2024 March | 23 | 18 | 41 |
| 2024 February | 22 | 19 | 41 |
| 2024 January | 30 | 11 | 41 |
| 2023 December | 20 | 17 | 37 |
| 2023 November | 23 | 26 | 49 |
| 2023 October | 26 | 36 | 62 |
| 2023 September | 28 | 25 | 53 |
| 2023 August | 31 | 14 | 45 |
| 2023 July | 29 | 31 | 60 |
| 2023 June | 44 | 13 | 57 |
| 2023 May | 52 | 9 | 61 |
| 2023 April | 35 | 3 | 38 |
| 2023 March | 37 | 3 | 40 |
| 2023 February | 49 | 2 | 51 |
| 2023 January | 4 | 2 | 6 |
| 2022 December | 15 | 14 | 29 |
| 2022 November | 10 | 3 | 13 |
Show all